Immuno-Biological Laboratories Co., Ltd.
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
4570 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 藤岡市中字東田１０９１番地１
- Website:
- https://www.ibl-japan.co.jp/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Immuno-Biological Laboratories Co., Ltd. (IBL) is a research-driven company that develops, manufactures, and supplies immunological research reagents and diagnostics. The company's portfolio includes ELISA kits, specialized antibodies, and cell culture-related products. IBL focuses on key therapeutic areas such as aging, neurodegenerative disorders, kidney diseases, inflammatory diseases, and glucose/lipid metabolism. A notable offering is the LipoSEARCH® lipoprotein analyzing system, which utilizes patented Gel Permeation High-Performance Liquid Chromatography (GP-HPLC) technology. The company collaborates with pharmaceutical partners and research institutions to support drug discovery and the development of novel diagnostics.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Immuno-Biological Laboratories Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 06:30 |
Regulatory News Service
臨時報告書
|
Japanese | 23.0 KB | |
| 2025-06-27 02:05 |
Regulatory News Service
内部統制報告書－第43期(2024/04/01－2025/03/31)
|
Japanese | 25.4 KB | |
| 2025-06-27 02:04 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-27 02:02 |
Annual Report
有価証券報告書－第43期(2024/04/01－2025/03/31)
|
Japanese | 1.2 MB | |
| 2024-11-14 01:04 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-11-14 01:02 |
Interim Report
半期報告書－第43期(2024/04/01－2025/03/31)
|
Japanese | 180.6 KB | |
| 2024-06-26 03:44 |
Regulatory News Service
臨時報告書
|
Japanese | 23.0 KB | |
| 2024-06-26 03:41 |
Regulatory News Service
内部統制報告書－第42期(2023/04/01－2024/03/31)
|
Japanese | 23.7 KB | |
| 2024-06-26 03:40 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-06-26 03:38 |
Annual Report
有価証券報告書－第42期(2023/04/01－2024/03/31)
|
Japanese | 1.2 MB | |
| 2024-02-14 01:10 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-02-14 01:07 |
Quarterly Report
四半期報告書－第42期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 161.4 KB | |
| 2023-11-14 01:02 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2023-11-14 01:01 |
Quarterly Report
四半期報告書－第42期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 190.6 KB | |
| 2023-08-14 02:08 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Immuno-Biological Laboratories Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Immuno-Biological Laboratories Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
